{"cluster": 20, "subcluster": 31, "abstract_summ": "The sensitivity of SARS-CoV-2 RT-PCR tests developed by Charite (Germany), HKU (Hong-Kong), China CDC (China), US CDC (United-States), and Institut Pasteur, Paris (France) was assessed on SARS-CoV-2 cell culture supernatants and clinical samples.Although all RT-PCR assays performed well for SARS-CoV-2 detection, RdRp Institut Pasteur (IP2, IP4), N China CDC, and N1 US CDC were found to be the most sensitive.Most tests for early detection of SARS-CoV-2 RNA rely on the reverse transcription-polymerase chain reaction, but isothermal nucleic acid ampli\ufb01cation assays, including transcription-mediated ampli\ufb01cation and CRISPR-based methodologies, are promising alternatives.Importance: The actual demand on SARS-CoV-2 diagnosis is a current challenge for clinical laboratories.We believe that our results may help clinical laboratories to respond to the actual demand and clinical need on SARS-CoV-2 testing, especially for the screening of low prevalence populations.", "title_summ": "Sample Pooling as an efficient strategy for SARS-COV-2 RT-PCR screening: a multicenter study in SpainSensitivity assessment of SARS-CoV-2 PCR assays developed by WHO referral laboratoriesAssay Techniques and Test Development for COVID-19 Diagnosis", "title_abstract_phrases": "Sensitivity assessment of SARS-CoV-2 PCR assays developed by WHO referral laboratoriesThe sensitivity of SARS-CoV-2 RT-PCR tests developed by Charite (Germany), HKU (Hong-Kong), China CDC (China), US CDC (United-States), and Institut Pasteur, Paris (France) was assessed on SARS-CoV-2 cell culture supernatants and clinical samples.Although all RT-PCR assays performed well for SARS-CoV-2 detection, RdRp Institut Pasteur (IP2, IP4), N China CDC, and N1 US CDC were found to be the most sensitive.Sample Pooling as an efficient strategy for SARS-COV-2 RT-PCR screening: a multicenter study in SpainImportance: The actual demand on SARS-CoV-2 diagnosis is a current challenge for clinical laboratories.This report describes various assay techniques and tests for COVID-19 diagnosis.We believe that our results may help clinical laboratories to respond to the actual demand and clinical need on SARS-CoV-2 testing, especially for the screening of low prevalence populations."}